SUZHOU ZHIYU BIOTECHNOLOGY CO.,LTD, established in 2009, operates as both an agent and manufacturer of finished-dosage pharmaceuticals and active ingredients spanning a wide therapeutic range, including oncology (Vindesine Sulfate, Vinorelbine Tartrate, Vincristine Sulfate, Carfilzomib Injection, Abemaciclib, Eribulin Mesilate Injection), anti-infectives (Isavuconazonium Sulfate, Fosfomycin, Amikacin Sulfate Injection), cardiovascular and metabolic drugs (SGLT2 inhibitors, Semaglutide, Empagliflozin, Dapagliflozin), CNS medications (Lamotrigine, Brivaracetam, Vigabatrin), and dermatological and respiratory formulations. The company offers CRO, CMO, and CDMO contract manufacturing services and sells into North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
No comments available.
Leave your rating & comment